Adenosinergic nature of antidepressant-induced antinociception in mice

Neuroscience Research Communications

Volumn 20, Issue 1, 1997, Pages 11-20

  Sierralta, F ^a   Pinardi, G ^a   Miranda, H F ^a  

^a UNIVERSITY OF CHILE   (Chile)

Author keywords

Aminophylline; Amitriptyline; Antidepressants imipramine; Antinociception; Maprotiline

Indexed keywords

ACETIC ACID; ADENOSINE; ADENOSINE RECEPTOR; AMINE; AMINOPHYLLINE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; IMIPRAMINE; MAPROTILINE; MORPHINE; NORADRENALIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; TIME; WRITHING TEST;

EID: 0031020540     PISSN: 08936609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-6769(199701)20:1<11::AID-NRC181>3.0.CO;2-E     Document Type: Article

References (28)

1. Acton, J., McKenna, J. E. and Melzack, R. (1992) Exp. Neurol. 117, 94.
2. Ardid, D. and Guilbaud, G. (1992) Pain 49, 279.
3. Couch, J. R., Ziegler, D. K. and Hassanein, R. (1976) Neurology 26, 121.
4. DeLander, G. E. and Hopkins, C. J. (1987) Eur. J. Pharmacol. 139, 215.
5. DeLander, G.E., Mosberg, H. I. and Porreca, F. (1992) J. Pharmacol. Exp. Ther. 263, 1097.
6. DeLander, G. E. and Gary, J. K. II. (1994) J. Pharmacol. Exp. Ther. 268, 943.
7. Enna, S. J. and Kendall, D. A. (1981) J. Clin. Psychopharmacol. 1, 12.
8. Feinmann C. (1985) Pain 23, 1.
9. Fredholm, B. B. (1995) Pharmacol. Toxicol. 76, 93.
10. MacNeil A. L. and Dick, W. C. (1976) J. Int. Med. Res. 4, 23.
11. Maggi, A., U'Prichard, D. C. and Enna S. J. (1980) Eur J. Pharmacol. 61, 91.
12. Magni, G. (1991) Drugs 42, 730.
13. McDonald Scott, W. A. (1967) Practitioner 202, 802.
14. Monks R. (1990) In: The Management of Pain, J. J. Bonica (ed). Lea & Febiger, Philadelphia, p. 1676.
15. Ossipov, M. H., Harris, S., Lloyd, P. and Messieneo, E. (1990) J. Pharmacol. Exper. Ther. 255, 1107.
16. Raffa, R. B., Friderichs, E., Reimann, W., Shank, R. P., Codd, E.E., Vaught, J.L., Jacoby, H. I. and Selve, N. (1993) J. Pharmacol. Exper. Ther. 267, 331.
17. Sawynok, J., Espey, M. J. and Reid, A. (1991) Neuropharmacology 30, 871.
18. Sawynok, J. and Reid, A. (1992) Pain 50, 113.
19. Sawynok, J. Sweeney, M. I. and White, T. D. (1989) Trends Pharmacol. Sci. 10, 186.
20. Sierralta, F., Pinardi, G. and Miranda, H. F. (1995) Pharmacol. Toxicol. 77, 276.
21. Sierralta, F. and Miranda H. F. (1993) Gen. Pharmacol. 24, 891.
22. Sierralta. F., Pinardi, G., Méndez, M. and Miranda H. F. (1995) Psychopharmacol. 122, 374.
23. Spiegel, K., Kalb, R.and Pasternak, G. W. (1983) Ann. Neurology 13, 462.
24. Stirt, J. A. (1983) Anaesthesia 38, 275.
25. Tallarida, R. J., Porreca, F. and Cowan, A. (1989) Life Sci. 45, 947.
26. Valeri, P., Pimpinella, G., Morrone, L. A. and Romanelli, L. (1991) Gen. Pharmacol. 22, 127.
27. Williams, M. (1984) Trends Pharmacol. Sci. 7, 164.
28. Yang, SW., Chen, J. Y., Zhang, Z. H., Xie, Y. F., Qiao, J. T. and Dafny, N. (1995) Brain Res. 673, 170.